Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    ICYMI: EI-1071 for IPF Earns Orphan Drug Status
    Sourced from: James Heilman, MD / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

    ICYMI: EI-1071 for IPF Earns Orphan Drug Status

      According to an August 2022 news release from biotechnology company Elixiron Immunotherapeutics (“Elixiron”), EI-1071, a therapy for patients with idiopathic pulmonary fibrosis (IPF), recently earned Orphan Drug designation from…

    Continue Reading ICYMI: EI-1071 for IPF Earns Orphan Drug Status
    Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs
    Source: https://unsplash.com/photos/ZHys6xN7sUE

    Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs

      Many patients with ankylosing spondylitis (AS) could be treated with biologics – in particular, biologic disease-modifying antirheumatic drugs (DMARDs). However, this line of treatment is not efficacious nor well-tolerated…

    Continue Reading Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs
    New Data Available on Paltusotine for Acromegaly
    source: unsplash.com

    New Data Available on Paltusotine for Acromegaly

      On September 9, 2022, researchers presented data at the European Neuroendocrine Association (ENEA) meeting. According to Yahoo! Finance, one such presentation centered around new safety and efficacy data from the…

    Continue Reading New Data Available on Paltusotine for Acromegaly
    Girl with Langerhans Cell Histiocytosis Receives New Playset
    https://pixabay.com/photos/swing-playground-children-playing-1188132/

    Girl with Langerhans Cell Histiocytosis Receives New Playset

    Victoria Acosta has always been an active child. The bubbly two-year-old, who currently lives in Tennessee, is described by her mother Andrea Rocha as constantly moving. However, it can be…

    Continue Reading Girl with Langerhans Cell Histiocytosis Receives New Playset
    Soticlestat Reduces Seizure Frequency in Dravet Syndrome, Study Shows
    https://pixabay.com/en/epilepsy-seizure-stroke-headache-623346/

    Soticlestat Reduces Seizure Frequency in Dravet Syndrome, Study Shows

    Both Dravet syndrome and Lennox-Gastaut syndrome (LGS) are characterized by frequent and often severe seizures. In many cases, those affected require multiple medications to manage their condition and prevent epileptic…

    Continue Reading Soticlestat Reduces Seizure Frequency in Dravet Syndrome, Study Shows